These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6537897)

  • 1. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
    Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
    Nigam VN; Brière N; Bonaventure J; Pageau R; Bissonnette E; Brailovsky C; Madarnas P
    Anticancer Res; 1986; 6(2):245-50. PubMed ID: 3085575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single and combined maltose tetrapalmitate immunotherapy, cyclophosphamide chemotherapy and radiotherapy on ethyl carbamate accelerated primary lung cancer in A/J mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    In Vivo; 1988; 2(2):159-65. PubMed ID: 2979834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
    Ibraheim EH; El Kappany H; Nigam VN; Brailovsky CA; Madarnas P; Elhilali MM
    Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN; Elhilali MM
    Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
    Soloway MS; Cox CE
    Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined effect of TNF and anticancer chemotherapeutic agents on murine bladder tumor (MBT-2)].
    Ikemoto S; Iimori H; Nishimoto K; Hayahara N; Kamizuru M; Wada S; Hayahara M
    Hinyokika Kiyo; 1992 Mar; 38(3):285-9. PubMed ID: 1523983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. II. Pathological studies.
    Madarnas P; Benrezzak O; Pageau R; Nigam VN; Elhilali M
    Anticancer Res; 1989; 9(6):1889-95. PubMed ID: 2627135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bladder cancer: chemotherapy of advanced bladder cancer].
    Koiso K
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):377-86. PubMed ID: 6820897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS
    Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
    Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoimmunotherapy of murine bladder cancer.
    Stogdill BJ; Lamm DL; Livingston RB
    Invest Urol; 1981 Nov; 19(3):179-81. PubMed ID: 7298287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the intravesical MTP and BCG treatment of transplantable bladder cancer.
    Elhilali MM; Ibrahim EH; Nigam VN; Brailovsky CA; Madarnas P
    J Urol; 1983 Jun; 129(6):1265-9. PubMed ID: 6854814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
    El Kappany H; Chopra C; Nigam VN; Brailovsky CA; Elhilali M
    Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.